How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review

SIMPLE SUMMARY: Recently observed improvement in the treatment of pancreatic ductal adenocarcinoma (PDAC) has resulted mainly from improved perioperative care and more effective chemotherapy. Over the past decade, there has been a gradual increase in the number of treatment options for pancreatic co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwaśniewska, Daria, Fudalej, Marta, Nurzyński, Paweł, Badowska-Kozakiewicz, Anna, Czerw, Aleksandra, Cipora, Elżbieta, Sygit, Katarzyna, Bandurska, Ewa, Deptała, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487031/
https://www.ncbi.nlm.nih.gov/pubmed/37686551
http://dx.doi.org/10.3390/cancers15174275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487031/
https://www.ncbi.nlm.nih.gov/pubmed/37686551
http://dx.doi.org/10.3390/cancers15174275

Ejemplares similares